United States· US:50474-808_385797e6-a44d-f4af-e063-6294a90a178a

Neupro

A medicinal product, registered in United States by UCB, Inc..

US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedNeuproATC—REGISTER NO.US:50474-808_385797e6…PACKS LISTED2CHECKEDSeptember 6, 2026

The record

At a glance

FDA National Drug Code directory (United States)
Manufacturer
UCB, Inc.
Country
United States (US)
ATC code
—
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 6, 2026

Packs & prices · 2

  • ndc11
    5047480811
    2 BOX in 1 KIT (50474-808-11) / 1 KIT in 1 BOX * 7 POUCH in 1 BOX / 1 PATCH in 1 POUCH / 24 h in 1 PATCH * 7 POUCH in 1 BOX / 1 PATCH in 1 POUCH / 24 h in 1 PATCH
  • ndc11
    50474-808-11

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/cb1ea075-c7ae-4f74-89e0-db1307f26a8a
GET /v1/drugs/cb1ea075-c7ae-4f74-89e0-db1307f26a8a?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": null,
  "source": "ndc",
  "strength": null,
  "substance": null,
  "productndc": "50474-808",
  "dosage_form": "KIT",
  "dea_schedule": null,
  "strength_unit": null,
  "application_number": "NDA021829",
  "marketing_category": "NDA"
}

See everything about Neupro.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.